Success Metrics

Clinical Success Rate
90.5%

Based on 38 completed trials

Completion Rate
90%(38/42)
Active Trials
6(11%)
Results Posted
37%(14 trials)
Terminated
4(7%)

Phase Distribution

Ph phase_1
3
5%
Ph phase_4
14
25%
Ph not_applicable
4
7%
Ph phase_2
17
30%
Ph phase_3
12
21%
Ph early_phase_1
1
2%

Phase Distribution

4

Early Stage

17

Mid Stage

26

Late Stage

Phase Distribution51 total trials
Early Phase 1First-in-human
1(2.0%)
Phase 1Safety & dosage
3(5.9%)
Phase 2Efficacy & side effects
17(33.3%)
Phase 3Large-scale testing
12(23.5%)
Phase 4Post-market surveillance
14(27.5%)
N/ANon-phased studies
4(7.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.9%

38 of 47 finished

Non-Completion Rate

19.1%

9 ended early

Currently Active

6

trials recruiting

Total Trials

57

all time

Status Distribution
Active(6)
Completed(38)
Terminated(9)
Other(4)

Detailed Status

Completed38
Recruiting6
Withdrawn5
Terminated4
unknown4

Development Timeline

Analytics

Development Status

Total Trials
57
Active
6
Success Rate
90.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.0%)
Phase 13 (5.9%)
Phase 217 (33.3%)
Phase 312 (23.5%)
Phase 414 (27.5%)
N/A4 (7.8%)

Trials by Status

recruiting611%
withdrawn59%
terminated47%
completed3867%
unknown47%

Recent Activity

Clinical Trials (57)

Showing 20 of 57 trialsScroll for more
NCT05946772Phase 2

Cyclosporine In Takotsubo Syndrome

Recruiting
NCT01962636Not Applicable

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Recruiting
NCT04877288Phase 3

A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Recruiting
NCT06658002Phase 3

Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A

Recruiting
NCT01595958Phase 3

Cyclosporine A in Cardiac Arrest

Completed
NCT02907554Phase 4

Cyclosporine a Pretreatment and Kidney Graft Function

Completed
NCT01706692

Swiss Dermatology Network of Targeted Therapies (SDNTT)

Recruiting
NCT03710044Phase 4

Investigation of Flare and Remission in Subjects With Atopic Dermatitis

Withdrawn
NCT04009525Phase 4

Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

Completed
NCT06512766

a Retrospective Study on the Systemic Treatment of LPP and FFA

Completed
NCT05794425Phase 1

Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders

Recruiting
NCT05323617Phase 2

Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy

Withdrawn
NCT04470804Phase 4

Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA

Completed
NCT05219656

Efficacy of Cyclosporine Rescue Therapy in Acute Ulcerative Colitis.

Completed
NCT00412360Phase 3

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Completed
NCT02707393Phase 2

Allogeneic Stem Cell Transplantation for Children With CML

Completed
NCT00001964Phase 2

Combination Therapy of Severe Aplastic Anemia

Completed
NCT00840827Phase 2

Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes

Terminated
NCT02617667Phase 2

CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)

Completed
NCT00383448Phase 2

HSCT for High Risk Inherited Inborn Errors

Completed

Drug Details

Intervention Type
DRUG
Total Trials
57